2010. Non-viral gene therapy for myocardial engineering. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2(3), 232–48., and
1995. Gene therapy for cardiovascular disease. Circulation, 91(2), 541–8.
2008. Gene therapy in heart failure. Circ. Res., 102(12), 1458–70., and
2011. Heart regeneration. Nature, 473(7347), 326–35. and
2010. Influence of substrate stiffness on the phenotype of heart cells. Biotechnol. Bioeng., 105(6), 1148–60., , et al.
1995. Tissue engineering: from biology to biological substitutes. Tissue Eng., 1(1), 3–13. and
2002. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation, 105(14), 1720–6., , et al.
1999. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation, 100(2), 193–202., , and
2000. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation, 102(19, Suppl. 3), III56–61., , et al.
2005. Electrospun fine-textured scaffolds for heart tissue constructs. Biomaterials, 26(26), 5330–8., , et al.
1999. Survival and function of bioengineered cardiac grafts. Circulation, 100(19, Suppl. 2), II63–9., , et al.
2003. Clinically established hemostatic scaffold (tissue fleece) as biomatrix in tissue- and organ-engineering research. Tissue Eng., 9(3), 517–23., , et al.
2001. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest., 108(3), 407–14., , et al.
2006. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell, 11(5), 723–32., and
2008. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature, 453(7194), 524–8., , et al.
2005. Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc. Nat. Acad. Sci. USA, 102(37), 13170–5., , , and
2006. Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation, 113(18), 2229–37., , et al.
2009. Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng. Part A, 15(6), 1211–22., , et al.
2009. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc. Nat. Acad. Sci. USA, 106(39), 16568–73., , et al.
2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663–76. and
2008. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation, 118(5), 507–17., , et al.
2009. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation, 120(15), 1513–23., , et al.
2009. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res., 104(4), e30–41., , et al.
2011. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ. Res., 109(1), 47–59., , et al.
1996. Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. J. Clin. Invest., 98(10), 2209–17., , , and
2011. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nature Cell Biol., 13(3), 215–22., , et al.
2009. Evidence for cardiomyocyte renewal in humans. Science, 324(5923), 98–102., , et al.
2010. Cardiomyogenesis in the adult human heart. Circ. Res., 107(2), 305–15., , et al.
2011. Bioengineering the infarcted heart by applying bio-inspired materials. J. Cardiovasc. Transl. Res., 4(5), 559–74., and
2003. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Nat. Acad. Sci. USA, 100(18), 10440–5., , et al.
2005. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Nat. Acad. Sci. USA, 102(24), 8692–7., , et al.
2006. Stem cell niches in the adult mouse heart. Proc. Nat. Acad. Sci. USA, 103(24), 9226–31., , et al.
2005. Post-natal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature, 433(7026), 647–53., , et al.
2008. Stem-cell therapy for cardiac disease. Nature, 451(7181), 937–42. and
2008. Stem-cell-based therapy and lessons from the heart. Nature, 453(7193), 322–9., and
2003. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6), 763–76., , et al.
2009. Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science, 326(5951), 426–9., , et al.
2004. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res., 95(9), 911–21., , et al.
2009. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation, 120(12), 1075–83, 7 pp. following 1083., , et al.
2010. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ. Res., 106(5), 971–80., , et al.
2001. Bone marrow cells regenerate infarcted myocardium. Nature, 410(6829), 701–5., , et al.
2001. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest., 107(11), 1395–402., , et al.
2003. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation, 107(9), 1247–9., , et al.
2003. Bone marrow stem cells regenerate infarcted myocardium. Pediatr. Transplant., 7(Suppl. 3), 86–8., , et al.
2001. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Nat. Acad. Sci. USA, 98(18), 10344–9., , et al.
2004. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol., 94(1), 92–5., , et al.
2006. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol., 24(4), 150–4., , et al.
2010. Myocardial regeneration potential of adipose tissue-derived stem cells. Biochem. Biophys. Res. Commun., 401(3), 321–6. and
2010. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur. Heart J., 31(4), 489–501., , et al.
2011. Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS One, 6(2), e15652., , et al.
2010. Challenges in cardiac tissue engineering. Tissue Eng. Part B Rev., 16(2), 169–87., , et al.
2008. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nature Mater., 7(12), 1003–10., , et al.
2003. High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol. Bioeng., 82(4), 403–14., , et al.
2002. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res., 90(2), 223–30., , et al.
2006. A novel perfusion bioreactor providing a homogenous milieu for tissue regeneration. Tissue Eng., 12(10), 2843–52., , and et al.
2003. Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials, 24(27), 5009–14., , et al.
2002. In vitro generation of differentiated cardiac myofibers on micropatterned laminin surfaces. J. Biomed. Mater. Res., 60(3), 472–9., , et al.
2002. Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng., 8(2), 175–88., , et al.
1999. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am. J. Physiol., 277(2, Part 2), H433–44., , et al.
1999. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol. Bioeng., 64(5), 580–9., , et al.
2002. Effects of oxygen on engineered cardiac muscle. Biotechnol. Bioeng., 78(6), 617–25., , et al.
2001. Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am. J. Physiol. Heart Circ. Physiol., 280(1), H168–78., , et al.
2008. Culture on electrospun polyurethane scaffolds decreases atrial natriuretic peptide expression by cardiomyocytes in vitro. Biomaterials, 29(36), 4783–91., , , and
2006. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation, 114(1 Suppl.), I72–8., , et al.
2006. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng., 12(8), 2077–91., , et al.
2005. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am. J. Physiol. Heart Circ. Physiol., 288(3), H1278–89., , and
2008. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nature Med., 14(2), 213–21., , et al.
2011. Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc. Nat. Acad. Sci. USA, 108(19), 7974–9., , et al.
2011. Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials, 32(5), 1280–90., , et al.
2002. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res., 90(3), e40., , et al.
2006. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J., 20(6), 708–10., , et al.
2005. Self-organization of rat cardiac cells into contractile 3-D cardiac tissue. FASEB J., 19(2), 275–7., , et al.
2011. Stem cell cultivation in bioreactors. Biotechnol. Adv., 29(6), 815–29., , , and
2005. Culture systems for pluripotent stem cells. J. Biosci. Bioeng., 100(1), 12–27., and
2007. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation, 115(7), 896–908., , et al.
2004. Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol. Bioeng., 86(5), 493–502., and
2011. Scalable expansion of multipotent adult progenitor cells as three-dimensional cell aggregates. Biotechnol. Bioeng., 108(2), 364–75., , and
2010. Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J. Biotechnol., 148(4), 208–15., , et al.
2004. Controlled, scalable embryonic stem cell differentiation culture. Stem Cells, 22(3), 275–82., , , and
2003. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng., 9(4), 767–78., , et al.
2005. Development of a perfusion fed bioreactor for embryonic stem cell-derived cardiomyocyte generation: oxygen-mediated enhancement of cardiomyocyte output. Biotechnol. Bioeng., 90(4), 452–61., , , and
2009. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol. Bioeng., 102(2), 493–507., , et al.
2008. Cardiomyocyte production in mass suspension culture: embryonic stem cells as a source for great amounts of functional cardiomyocytes. Tissue Eng. Part A, 14(10), 1591–601., , et al.
2003. Bioreactors for cardiovascular cell and tissue growth: a review. Ann. Biomed. Eng., 31(9), 1017–30., , , and
2006. Bioreactors for tissue engineering. Biotechnol. Lett., 28(18), 1415–23. and
2005. Engineering myocardial tissue. Circ. Res., 97(12), 1220–31. and
2008. Cardiac tissue engineering using perfusion bioreactor systems. Nature Protoc., 3(4), 719–38., , et al.
2008. Pulsatile perfusion bioreactor for cardiac tissue engineering. Biotechnol. Prog., 24(4), 907–20., and
2004. The role of bioreactors in tissue engineering. Trends Biotechnol., 22(2), 80–6., and
2005. Bioreactor design for tissue engineering. J. Biosci. Bioeng., 100(3), 235–45., , , and
2009. Enhancing cardiac stem cell differentiation into cardiomyocytes. Cardiovasc. Res., 82(3), 385–7., and
2010. Perfusion seeding of channeled elastomeric scaffolds with myocytes and endothelial cells for cardiac tissue engineering. Biotechnol. Prog., 26(2), 565–72., , and
2011. Engineered cardiac tissues. Curr. Opin. Biotechnol., 22(5), 706–14., , and
2010. Bioactive scaffolds for engineering vascularized cardiac tissues. Macromolec. Biosci, 10(11), 1286–301., and
2009. Biomimetic approach to tissue engineering. Semin. Cell Dev. Biol., 20(6), 665–73., , , and
2007. Engineering the heart piece by piece: state of the art in cardiac tissue engineering. Regen. Med., 2(2), 125–44. and
2004. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Nat. Acad. Sci. USA, 101(52), 18129–34., , et al.
2009. Electrical stimulation systems for cardiac tissue engineering. Nature Protoc., 4(2), 155–73., , et al.
2009. Differentiation of human adult cardiac stem cells exposed to extremely low-frequency electromagnetic fields. Cardiovasc. Res., 82(3), 411–20., , et al.
2006. Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng., 12(12), 3285–305., , et al.
2003. Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties. Tissue Eng., 9(6), 1243–53., , et al.
2004. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am. J. Physiol. Heart Circ. Physiol., 286(2), H507–16., , et al.
2007. Development of a novel pulsatile bioreactor for tissue culture. J. Artif. Organs, 10(2), 109–14., , and
2006. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nature Med., 12(4), 452–8., , et al.
2002. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation, 106(12, Suppl. 1), I137–42., , et al.
2011. Biphasic electrical field stimulation AIDS in tissue engineering of multicell-type cardiac organoids. Tissue Eng. Part A, 17(11–12), 1465–77., , and
2011. Optimization of electrical stimulation parameters for cardiac tissue engineering. J. Tissue Eng. Regen. Med., 5(6), e115–25., , et al.
2010. Electric field stimulation integrated into perfusion bioreactor for cardiac tissue engineering. Tissue Eng. Part C Methods, 16(6), 1417–26., , et al.
2009. Cell culture chips for simultaneous application of topographical and electrical cues enhance phenotype of cardiomyocytes. Lab Chip, 9(4), 564–75., , , and
2011. A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation. Tissue Eng. Part C Methods, 17(4), 463–73., , et al.
2007. Micro-bioreactor array for controlling cellular microenvironments. Lab Chip, 7(6), 710–19., , et al.
2010. Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue. Proc. Nat. Acad. Sci. USA, 107(8), 3329–34., , et al.
2009. Cardiac cells implanted into a cylindrical, vascularized chamber in vivo: pressure generation and morphology. Biotechnol. Lett., 31(2), 191–201., , et al.
2007. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation, 115(3), 353–60., , et al.
1999. Fetal cell transplantation: a comparison of three cell types. J. Thorac. Cardiovasc. Surg., 118(4), 715–24., , et al.
1995. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann. Thorac. Surg., 60(1), 12–18., and
1996. Skeletal myoblast transplantation for repair of myocardial necrosis. J. Clin. Invest., 98(11), 2512–23., , and
1998. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nature Med., 4(8), 929–33., , et al.
2000. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J. Thorac. Cardiovasc. Surg., 119(6), 1169–75., , et al.
2011. Cell delivery in cardiac regenerative therapy. Ageing Res. Rev., 11(1), 32–40., , and
2001. Myoblast transplantation for heart failure. Lancet, 357(9252), 279–80., , et al.
2003. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol., 41(7), 1078–83., , et al.
2002. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 106(15), 1913–18., , et al.
2004. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364(9429), 141–8., , et al.
2006. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med., 355(12), 1210–21., , et al.
2005. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J. Am. Coll. Cardiol., 46(9), 1651–8., , et al.
2009. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol., 54(24), 2277–86., , et al.
2011. Stem cell therapy for cardiac disease. Expert Opin. Biol. Ther., 11(2), 177–87. and
2005. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc. Nat. Acad. Sci. USA, 102(10), 3766–71., , et al.
2006. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation, 113(10), 1287–94., , et al.
2002. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation, 106(24), 3009–17., , et al.
2011. CD34+ autologous human stem cells in treating refractory angina. Circ. Res., 109(4), 351–2. and
2007. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ. Res., 100(8), 1234–41., , et al.
2011. A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am. Heart J., 161(6), 1078–87., , et al.
2006. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation, 114(1 Suppl.), I145–51., , et al.
2007. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur. Heart J., 28(24), 2998–3005., , et al.
2009. One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc. Interv., 2(1), 9–16., , et al.
2006. Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets. Tissue Eng., 12(3), 499–507., , et al.
2008. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation, 118(14 Suppl.), S145–52., , et al.
2010. Design of prevascularized three-dimensional cell-dense tissues using a cell sheet stacking manipulation technology. Biomaterials, 31(7), 1646–54., , et al.
2010. Pre-vascularization of in vitro three-dimensional tissues created by cell sheet engineering. Biomaterials, 31(14), 3903–9., , et al.
2005. A new method for manufacturing cardiac cell sheets using fibrin-coated dishes and its electrophysiological studies by optical mapping. Artif. Organs, 29(2), 95–103., , et al.
2011. Advances in cell transplantation therapy for diseased myocardium. Stem Cells Int., 679171., , et al.
2005. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J. Thorac. Cardiovasc. Surg., 130(5), 1333–41., , et al.
2011. Bcl-2 improves myoblast sheet therapy in rat chronic heart failure. Tissue Eng. Part A, 17(1–2), 115–25., , et al.
2009. Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart. J. Thorac. Cardiovasc. Surg., 138(2), 460–7., , et al.
2010. Impaired myocardium regeneration with skeletal cell sheets–a preclinical trial for tissue-engineered regeneration therapy. Transplantation, 90(4), 364–72., , et al.
2010. Myocardial regeneration for heart failure [in Japanese]. Nippon Rinsho, 68(4), 719–25.
2006. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nature Med., 12(4), 459–65., , et al.
2010. Cardiomyoblast-like cells differentiated from human adipose tissue-derived mesenchymal stem cells improve left ventricular dysfunction and survival in a rat myocardial infarction model. Tissue Eng. Part C Methods, 16(3), 417–25., , et al.
2010. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Cardiovasc. Res., 87(1), 40–9., , et al.
2006. Electrical coupling of cardiomyocyte sheets occurs rapidly via functional gap junction formation. Biomaterials, 27(27), 4765–74., , et al.
2006. Pulsatile myocardial tubes fabricated with cell sheet engineering. Circulation, 114(1 Suppl.), I87–93., , , and
2005. Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium. Transplantation, 80(11), 1586–95., , et al.
2002. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation, 106(12, Suppl. 1), I151–7., , et al.
2007. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells, 25(9), 2350–7., , , and
2001. Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue. Circulation, 104(17), 2063–8., , et al.
2005. Bone marrow cell-seeded biodegradable polymeric scaffold enhances angiogenesis and improves function of the infarcted heart. Circ. J., 69(7), 850–7., , et al.
2011. Tissue-engineered cardiac constructs for cardiac repair. Ann. Thorac. Surg., 91(1), 320–9., , , and
2008. Myocardial tissue engineering. Br. Med. Bull., 87, 31–47., , , et al.
2009. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in swine. J. Am. Coll. Cardiol., 54(11), 1014–23., , et al.
2002. Optimal biomaterial for creation of autologous cardiac grafts. Circulation, 106(12, Suppl. 1), I176–82., , et al.
2003. Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J. Biomed. Mater. Res. A, 66(3), 586–95., , , and
2002. In vitro engineering of heart muscle: artificial myocardial tissue. J. Thorac. Cardiovasc. Surg., 124(1), 63–9., , et al.
2008. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): clinical feasibility study. Ann. Thorac. Surg., 85(3), 901–8., , et al.
2003. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation, 108(Suppl. 1), II219–25., , et al.
2006. Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure. J. Thorac. Cardiovasc. Surg., 132(1), 124–31., , et al.
2011. Development and evaluation of a perfusion decellularization porcine heart model – generation of 3-dimensional myocardial neoscaffolds. Circ. J., 75(4), 852–60., , et al.
2010. Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng. Part C Methods, 16(3), 525–32., , et al.
2009. From stem cells and cadaveric matrix to engineered organs. Curr. Opin. Biotechnol., 20(5), 598–605.
2002. From lab bench to market: critical issues in tissue engineering. Ann. NY Acad. Sci., 961, 372–85.